Filing Details
- Accession Number:
- 0001144204-19-015117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-20 16:07:51
- Reporting Period:
- 2018-03-18
- Accepted Time:
- 2019-03-20 16:07:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1268135 | Arthur Przybyl | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-18 | 24,802 | $63.53 | 205,076 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-03-19 | 2,823 | $63.51 | 205,076 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2019-03-18 | 6,375 | $0.00 | 6,375 | $33.00 |
| Common Stock | Stock Options | Disposition | 2019-03-18 | 9,375 | $0.00 | 9,375 | $40.59 |
| Common Stock | Stock Options | Disposition | 2019-03-18 | 9,052 | $0.00 | 9,052 | $49.51 |
| Common Stock | Stock Options | Disposition | 2019-03-19 | 2,823 | $0.00 | 2,823 | $49.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-03-31 | No | 4 | M | Direct | |
| 18,750 | 2026-04-06 | No | 4 | M | Direct | |
| 38,448 | 2027-03-30 | No | 4 | M | Direct | |
| 35,625 | 2027-03-30 | No | 4 | M | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
- The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
- Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014.
- Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016.
- Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017.
Billionaire Hedge Funds
